Global Anemia Therapeutics Market 2017-2021

貧血治療薬の世界市場2017-2021:鉄欠乏症貧血、鎌状赤血球貧血、悪性貧血、溶血性貧血、その他

◆タイトル:Global Anemia Therapeutics Market 2017-2021
◆商品コード:IRTNTR14378
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2017年10月18日
◆ページ数:84
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療・バイオ・製薬
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

Technavio社が発行した当調査レポートでは、貧血治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、貧血治療薬の世界市場規模及び予測、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。Technavio社は貧血治療薬の世界市場が2017-2021年期間中に年平均8.55%成長すると予測しています。当レポート上に記載されている主な企業は、AMAG Pharmaceuticals、Daiichi Sankyo、Galenica、Pharmacosmos等です。

About Anemia Therapeutics
It is a medical condition that is characterized by the decrease in RBC count. RBCs make up the blood, and its main function is to deliver oxygen from lungs to other tissues and carbon dioxide from other tissues back to the lungs. This function is accomplished by hemoglobin, an iron-containing biomolecule present at the cytoplasm of an RBC and can efficiently bind to oxygen. In anemia, the decreased RBC count results in the impairment of the body’s ability for gas exchange (oxygen and carbon dioxide). This decrease may result from hemolysis (destruction of RBC), hemorrhage (blood loss), or decreased production of RBCs.

Technavio’s analysts forecast the global anemia therapeutics market to grow at a CAGR of 8.55% during the period 2017-2021 .

[Covered in this report]
The report covers the present scenario and the growth prospects of the global anemia therapeutics market for 2017-2021 . To calculate the market size, the report considers the sales of branded, generic, and off-label drugs used for the treatment of anemia.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Anemia Therapeutics Market 2017-2021 , has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• AMAG Pharmaceuticals
• Daiichi Sankyo
• Galenica
• Pharmacosmos

[Other prominent vendors]
• Acceleron Pharma
• Bayer
• GlycoMimetics
• GlaxoSmithKline
• Novartis
• Pieris Pharmaceuticals
• Sanofi

[Market driver]
• Presence of large patient pool with various disorders
• For a full, detailed list, view our report

[Market challenge]
• High cost of drugs
• For a full, detailed list, view our report

[Market trend]
• Growing focus on emerging economies
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

Table of Contents
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
• Market outline

PART 05: Anemia: A brief overview
• Anemia
• Symptoms
• Classification of anemia
• Causes of anemia
• Treatment

PART 06: Market landscape
• Market overview
• Five forces analysis

PART 07: Pipeline Landscape

PART 08: Market segmentation by disease type
• Iron deficiency anemia
• Sickle cell anemia
• Pernicious anemia
• Hemolytic anemia
• Others

PART 09: Geographical segmentation
• Anemia therapeutics market in Americas
• Anemia therapeutics market in EMEA
• Anemia therapeutics market in APAC

PART 10: Decision framework

PART 11: Drivers and challenges
• Market drivers
• Market challenges

PART 12: Market trends
• Growing focus on HIF stabilizers
• Growing focus on emerging economies
• Increasing strategies of vendors to expand reach of anemia therapeutics

PART 13: Vendor landscape
• Competitive scenario

PART 14: Key vendor analysis
• AMAG Pharmaceuticals
• Daiichi Sankyo
• Galenica
• Pharmacosmos
• Other prominent vendors

PART 15: Appendix
• List of abbreviations

[List of Exhibits]
Exhibit 01: Complications arising due to anemia
Exhibit 02: Symptoms of anemia
Exhibit 03: Classification of anemia
Exhibit 04: Causes of anemia
Exhibit 05: Treatment approaches for anemia
Exhibit 06: Global anemia therapeutics market
Exhibit 07: Global anemia therapeutics market, 2016-2021 ($ billions)
Exhibit 08: Use of anemia therapeutics
Exhibit 09: Opportunity analysis of global anemia therapeutics market
Exhibit 10: Five forces analysis
Exhibit 11: Pipeline landscape by number of molecules
Exhibit 12: Key clinical trials
Exhibit 13: Global anemia therapeutics market segmentation by disease type
Exhibit 14: Global anemia therapeutics market share by disease type, 2016
Exhibit 15: Global iron deficiency anemia therapeutics market, 2016-2021 ($ billions)
Exhibit 16: Global sickle cell anemia therapeutics market, 2016-2021 ($ billions)
Exhibit 17: Global pernicious anemia therapeutics market, 2016-2021 ($ billions)
Exhibit 18: Types of hemolytic anemia
Exhibit 19: Global hemolytic anemia therapeutics market, 2016-2021 ($ billions)
Exhibit 20: Global anemia therapeutics market by others, 2016-2021 ($ billions)
Exhibit 21: Global anemia therapeutics market share by geography, 2016 and 2021
Exhibit 22: Global anemia therapeutics market by geography, 2016-2021 ($ billions)
Exhibit 23: Market scenario in Americas
Exhibit 24: Anemia therapeutics market in Americas ($ billions)
Exhibit 25: Market scenario in EMEA
Exhibit 26: Anemia therapeutics market in EMEA ($ billions)
Exhibit 27: Market scenario in APAC
Exhibit 28: Anemia therapeutics market in APAC ($ billions)
Exhibit 29: Competitive structure analysis of global anemia therapeutics market 2016
Exhibit 30: AMAG Pharmaceuticals: Key highlights
Exhibit 31: AMAG Pharmaceuticals: Strength assessment
Exhibit 32: AMAG Pharmaceuticals: Strategy assessment
Exhibit 33: AMAG Pharmaceuticals: Opportunity assessment
Exhibit 34: Daiichi Sankyo: Key highlights
Exhibit 35: Daiichi Sankyo: Strength assessment
Exhibit 36: Daiichi Sankyo: Strategy assessment
Exhibit 37: Daiichi Sankyo: Opportunity assessment
Exhibit 38: Galenica: Key highlights
Exhibit 39: Galenica: Strength assessment
Exhibit 40: Galenica: Strategy assessment
Exhibit 41: Galenica: Opportunity assessment
Exhibit 42: Pharmacosmos: Key highlights
Exhibit 43: Pharmacosmos: Strength assessment
Exhibit 44: Pharmacosmos: Strategy assessment
Exhibit 45: Pharmacosmos: Opportunity assessment



【掲載企業】

AMAG Pharmaceuticals, Daiichi Sankyo, Galenica, Pharmacosmos, Acceleron Pharma, Bayer, GlycoMimetics, GlaxoSmithKline, Novartis, Pieris Pharmaceuticals, and Sanofi.


★調査レポート[貧血治療薬の世界市場2017-2021:鉄欠乏症貧血、鎌状赤血球貧血、悪性貧血、溶血性貧血、その他] (Global Anemia Therapeutics Market 2017-2021 / IRTNTR14378)販売に関する免責事項
[貧血治療薬の世界市場2017-2021:鉄欠乏症貧血、鎌状赤血球貧血、悪性貧血、溶血性貧血、その他] (Global Anemia Therapeutics Market 2017-2021 / IRTNTR14378)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆